These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticholinergic psychosis in a bilingual: a case study. Laski E; Taleporos E Am J Psychiatry; 1977 Sep; 134(9):1038-40. PubMed ID: 900288 [No Abstract] [Full Text] [Related]
5. A case report of vomiting related to the interactions of antipsychotics and benztropine. Schaffer CB; Shahid A; Javaid JI; Davis JM Am J Psychiatry; 1981 Jun; 138(6):833-5. PubMed ID: 6113771 [No Abstract] [Full Text] [Related]
6. Protracted vomiting following abrupt cessation of psychotropics: a case report. Kalman T; Warner GM Can Psychiatr Assoc J; 1978 Apr; 23(3):163-5. PubMed ID: 647615 [TBL] [Abstract][Full Text] [Related]
7. Delirium and stereotypy from anticholinergic antiparkinson drugs. Kulik AV; Wilbur R Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):75-82. PubMed ID: 7202232 [TBL] [Abstract][Full Text] [Related]
8. Mutism and hyperthermia in a patient treated with neuroleptics. Oppenheim G Med J Aust; 1973 Aug; 2(5):228-9. PubMed ID: 4744098 [No Abstract] [Full Text] [Related]
9. Atypical tardive dyskinesia. Moline RA Am J Psychiatry; 1975 May; 132(5):534-5. PubMed ID: 1119614 [TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in the absence of leukopenia associated with the use of neuroleptics. Storrie MC; Scher M; McGuire J; Bokan J J Clin Psychiatry; 1978 Oct; 39(10):779-81. PubMed ID: 711689 [TBL] [Abstract][Full Text] [Related]
11. Antiparkinson drugs as causal agents in tardive dyskinesia. Kiloh LG; Smith JS; Williams SE Med J Aust; 1973 Sep; 2(12):591-3. PubMed ID: 4149942 [No Abstract] [Full Text] [Related]
12. The withdrawal of benztropine mesylate in chronic schizophrenic patients. Baker LA; Cheng LY; Amara IB Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765 [TBL] [Abstract][Full Text] [Related]
13. Propranolol, benztropine, fluphenazine decanoate, and delirium. Lima BR; Vanneman D Am J Psychiatry; 1983 May; 140(5):659-60. PubMed ID: 6846615 [No Abstract] [Full Text] [Related]
14. Anticholinergic toxic psychosis in drug abusers treated with benztropine. Woody GE; O'Brien CP Compr Psychiatry; 1974; 15(5):439-42. PubMed ID: 4412051 [No Abstract] [Full Text] [Related]
15. Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study. el-Yousef MK; Janowsky D; Davis JM; Sekerke HJ Am J Psychiatry; 1973 Feb; 130(2):141-5. PubMed ID: 4405503 [No Abstract] [Full Text] [Related]
16. Effects of benztropine mesylate (Cogentin) on accommodation in normal volunteers. Thaler JS Am J Optom Physiol Opt; 1982 Nov; 59(11):918-9. PubMed ID: 7180936 [No Abstract] [Full Text] [Related]
17. Anticholinergic effects on memory: benztropine vs. amantadine. Van Putten T; Gelenberg AJ; Lavori PW; Falk WE; Marder SR; Spring B; Mohs RC; Brotman AW Psychopharmacol Bull; 1987; 23(1):26-9. PubMed ID: 3602326 [No Abstract] [Full Text] [Related]
18. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate. Siris SG; Rifkin A; Reardon GT; November M Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910 [TBL] [Abstract][Full Text] [Related]
19. Haloperidol and benztropine interaction presenting as acute intestinal pseudo-obstruction. Sheikh RA; Prindiville T; Yasmeen S Am J Gastroenterol; 2001 Mar; 96(3):934-5. PubMed ID: 11280595 [No Abstract] [Full Text] [Related]